10-K

Company

Hepion Pharmaceuticals, Inc.

Filed

September 28, 2016

Period of Report

June 30, 2016

Accession Number

0001104659-16-147194

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →